FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved Epic Pharma, LLC's supplemental application to market a generic nizatidine product (an H2 receptor blocker) under an ANDA, expanding available gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastritis
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Nizatidine (nizatidine)

Snippet

SUPPL AP for NIZATIDINE (NIZATIDINE)